At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 171 enrolled
Drug / intervention
Point-of-care washed red blood cell transfusion. +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
In Brief
A Phase 2 clinical trial evaluating Point-of-care washed red blood cell transfusion. and Standard of care red blood cell transfusion. for Blood Transfusion Complications. Completed, enrolled 171 participants across 2 sites.
Detailed Summary
This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Transfusion Complications
CountriesUnited States
CollaboratorsDuke University, Vitalant Research Institute
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartJan 2016
Primary CompletionMay 2019
TodayJul 2026
First PostedMar 21, 2014
Enrollment StartJan 1, 2016
Primary CompletionMay 30, 2019
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 12.3 years ago
Interventions
Point-of-care washed red blood cell transfusion.biological
Standard of care red blood cell transfusion.biological